A study published in Scientific Reports has identified specific blood metabolic pathways that link diet and physical activity to functional performance across the cognitive aging spectrum—from healthy aging to Alzheimer's disease.
Higher levels of a newly derived lifestyle-related metabolic score were associated with better mobility, cognition, independence, and lower frailty.
Key Findings & Methodology
The research analyzed data from three major aging studies: the Alzheimer's Disease Neuroimaging Initiative (ADNI), the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), and the Australian Imaging, Biomarkers, and Lifestyle Study of Aging (AIBL).
- Participants: 360 total—150 cognitively normal (CN), 120 with mild cognitive impairment (MCI), and 90 with Alzheimer's disease (AD).
- Lifestyle Assessment: Diet quality was measured via a Food Frequency Questionnaire; physical activity was assessed using the International Physical Activity Questionnaire.
- Functional Outcomes: The study measured gait speed, activities of daily living, grip strength, global cognition, a composite function score, and frailty.
The Science: From Lifestyle to Pathways
Fasting blood samples underwent metabolomics analysis. Researchers mapped the data to metabolic pathways and created a Lifestyle-Modulated Metabolic Pathway Score (LMPS) using advanced statistical modeling.
The key pathways that showed structured differences across the groups included:
- Amino acid metabolism
- Energy metabolism
- Lipid metabolism
- Oxidative stress and inflammation pathways
- Microbiome-related metabolism
Strongest Associations in Cognitively Normal Individuals
The LMPS showed the strongest positive association with better functional outcomes in the cognitively normal group. A higher LMPS was also linked to lower frailty across all groups. This suggests that lifestyle-driven metabolic patterns may be most influential before significant cognitive decline sets in.
Study Limitations
The authors note several important caveats:
- Cross-sectional design: Cannot establish cause-and-effect relationships.
- No external validation cohort: The LMPS is considered hypothesis-generating, not a validated biomarker.
- Untargeted metabolomics: Reflects relative intensities, not absolute concentrations.
Conclusion
Pathway-level metabolomics successfully identified coordinated metabolic patterns that connect lifestyle choices to functional outcomes in cognitive aging.
These findings provide a new framework for understanding how diet and exercise influence aging at the molecular level, though further validation is needed before the LMPS can be used as a clinical tool.